Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human Platelet Derived Growth Factors (PDGF) are potent mitogens for mesenchymal cells and encoded by two related genes, the A- (or 1-) and B- (or 2-) chain. The latter is known as the human homolog (c-sis) of the v-sis oncogene. We investigated the expression and cytokine-mediated regulation of PDGF A- and B-chain mRNA in endoderm-derived cells, i.e. cultured human pancreatic adenocarcinoma cells. Northern blot analysis revealed that out of 14 cells lines 11 were positive for the A-chain and 10 for the B-chain. Tumor Necrosis Factor (TNF) -alpha and -beta, but not Interferon (IFN) -gamma, drastically upregulate the mRNA levels for
PDGF B-chain
and for the A-chain in a dose-dependent manner in nearly every pancreatic tumor cell line investigated (n = 6). With respect to the signal pathway stimulated by TNF, no evidence emerged for an activation of protein kinase A. The inhibition of
protein kinase C
by staurosporine (in the absence or presence of TNF) as well as its stimulation by PMA resulted in an increased mRNA level for the B-chain, indicating a functional role of
PKC
in this system. Furthermore, time course experiments and Cycloheximide treatment showed that the A- and B-chain mRNA are regulated by different mechanisms in transformed epithelial cells. Irrespective of these differences, the sum of their biological functions may contribute to the phenomenon of desmoplasia in pancreatic tumors by epithelial/mesenchymal interactions.
...
PMID:Modulation of platelet-derived growth factor A- and B-chain/c-sis mRNA by tumor necrosis factor and other agents in adenocarcinoma cells. 190 54
Thrombin is a potent mitogen for mesangial cells and stimulates
PDGF B-chain
gene expression in these cells. It also activates phospholipase C (PLC) resulting in an increase in cytosolic Ca2+ and diacylglycerol (DAG) that are the physiological activators of
protein kinase C
(
PKC
). Immunoprecipitation of specific
PKC
isotypes from thrombin-stimulated mesangial cells with subsequent measurement of their enzymatic activity shows activation of Ca(2+)-dependent
PKC
alpha and Ca(2+)-independent PKC zeta in a time dependent manner. Optimum activation of both of these isozymes was obtained at 60 minutes.
PKC
alpha activity increased 83% over basal while activity of PKC zeta increased 104%. Prolonged exposure of mesangial cells to phorbol myristate acetic acid (PMA) inhibited the enzymatic activity of
PKC
alpha but not PKC zeta. This inhibition of
PKC
alpha had no effect on thrombin-induced DNA synthesis but abolished
PDGF B-chain
gene expression induced by thrombin. These data provide the first evidence that
PKC
alpha activation is necessary for thrombin-induced
PDGF B-chain
gene expression but not for thrombin-induced DNA synthesis.
...
PMID:PKC alpha regulates thrombin-induced PDGF-B chain gene expression in mesangial cells. 758 54
Fluid flow and the associated shear stress play a critical role in vascular growth and remodeling. Recent data suggest that increased endothelial cell expression of platelet-derived growth factor (PDGF) A- and B-chain by flow may participate in these events. In the present study, we examined the mechanism for flow-induced PDGF expression, focusing on
protein kinase C
(
PKC
). Bovine aortic endothelial cells were exposed to flow (shear stress = 30 dyn/cm2) in a parallel-plate flow chamber. Increases in
PDGF B-chain
, but not PDGF A-chain, were observed within 3 h, maximal within 6 h (13-fold increase), and sustained for 24 h.
PKC
appeared to be involved because phorbol 12-myristate 13-acetate induced
PDGF B-chain
mRNA. Activation of
PKC
alone, however, was insufficient to induce PDGF mRNA because the selective
PKC
activator, 1-oleoyl-2-acetyl-sn-glycerol, did not induce PDGF expression. A
PKC
-independent pathway was suggested by the fact that inhibition of
PKC
(downregulation with phorbol 12,13-dibutyrate or exposure to staurosporine) failed to block PMA or flow-induced
PDGF B-chain
expression. These results demonstrate flow-induced
PDGF B-chain
expression in endothelial cells that appears to be mediated, in part, by a
PKC
-independent pathway.
...
PMID:Fluid shear stress stimulates platelet-derived growth factor expression in endothelial cells. 834 46
Platelet-derived growth factor (PDGF) is a broadly expressed mitogenic and chemotactic factor with diverse roles in a number of physiologic and pathologic settings. The zinc finger transcription factors Sp1, Sp3 and Egr-1 bind to overlapping elements in the proximal
PDGF B-chain
promoter and activate transcription of this gene. The anthracycline nogalamycin has previously been reported to inhibit the capacity of Egr-1 to bind DNA in vitro. Here we used electrophoretic mobility shift assays to show that nogalamycin added to cells in culture did not alter the interaction of Egr-1 with the PDGF-B promoter. Instead, it enhanced the capacity of Sp1 to bind DNA. Nogalamycin increased PDGF-B mRNA expression at the level of transcription, which was abrogated by mutation of the Sp1 binding site in the PDGF-B promoter or overexpression of mutant Sp1. Rather than increasing total levels of Sp1, nogalamycin altered the phosphorylation state of the transcription factor. Overexpression of dominant-negative
PKC
-zeta blocked nogalamycin-inducible Sp1 phosphorylation and PDGF-B promoter-dependent expression. Nogalamycin stimulated the phosphorylation of
PKC
-zeta (on residue Thr(410)). These findings demonstrate for the first time that
PKC
-zeta and Sp1 phosphorylation mediate the inducible expression of this growth factor.
...
PMID:Sp1 phosphorylation regulates inducible expression of platelet-derived growth factor B-chain gene via atypical protein kinase C-zeta. 1122 51